ArticleJPGN reports2026
A case report of non-syndromic colonic ganglioneuroma in a patient with juvenile polyposis.
Article in JPGN reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colonic ganglioneuromas in children are rare, particularly without associated hereditary syndromes like multiple endocrine neoplasia (MEN2B), neurofibromatosis type 1(NF1), or Phosphatase and tensin homolog hamartoma tumor syndrome (PHTS). We report a 12-year-old male with a history of juvenile polyposis syndrome (JPS) and segmental colonic resection for high distal disease burden. During surveillance colonoscopy, a solitary ascending colon polyp was retrieved and found to be a ganglioneuroma. Genetic testing showed gl-9 family hypoxia inducible factor 1 and succinate dehydrogenase complex flavoprotein subunit A variants in the patient and MutL homolog 3 and MutS homolog 3 variants in both the patient and his mother. All genes discovered were classified as variants of uncertain significance. There was no genetic or clinical evidence of MEN2B, NF1, or PHTS. This case highlights that JPS is a heterogenous disorder and may involve increased risk of developing unique polyp subtypes which are not typically associated with that condition. Current JPS recommendations suggest that surveillance colonoscopy may be performed every 3 years which may be insufficient in situations involving novel mutations or unknown JPS genetics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.